General Information of the Compound
| Compound ID |
CP0663918
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
SID50113017
Show/Hide
|
||||||||||||||||||
| Synonyms |
E-0646
E-2000
E-2000 (oral), Eisai
E-2000 (transdermal patch), Eisai
E-646
EMPP
Eperisone
Eperisone (oral), Eisai
Eperisone (transdermal patch)
Eperisone (transdermalpatch), Eisai
Myonal
Myorelark
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H25NO
|
||||||||||||||||||
| Molecular Weight |
259.393
|
||||||||||||||||||
| Canonical SMILES |
CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H25NO/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18/h7-10,14H,3-6,11-13H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
SQUNAWUMZGQQJD-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
124308-54-9
64840-90-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00817, Cytochrome P450 2D6
Protein ID: PT06109, Geminin
Clinical Information about the Compound